ArticleHeliyon2024

Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis.

Lijuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.